Rebecca Rebbe , Margaret Lloyd Sieger , Julia Reddy , John Prindle
{"title":"U.S. State rates of newborns reported to child protection at birth for prenatal substance exposure","authors":"Rebecca Rebbe , Margaret Lloyd Sieger , Julia Reddy , John Prindle","doi":"10.1016/j.drugpo.2024.104527","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In the U.S., the opioid epidemic has revitalized national attention to newborns with prenatal substance exposure (PSE). These newborns and their caregivers have specific health and treatment needs and frequently interact with multiple systems, including child protection systems (CPS).</p></div><div><h3>Methods</h3><p>This study calculated rates of newborns (less than 15 days old) reported to CPS per 1,000 births due to PSE by state and year using data from the National Child Abuse and Neglect Data System (NCANDS). Given the lack of a clear definition of PSE reports in the data, we calculated rates using three different definitions. To examine the relationship between different state laws regarding the mandated reporting of PSE and PSE reports rates, we used panel data analysis.</p></div><div><h3>Results</h3><p>Rates of newborn reports more than doubled between 2011 and 2019. There was extensive state variability of rates including some states that were consistently more than 100 % greater than and others consistently more than 150 % less than the annual national mean. Reporting rates were not associated with state requirements to report PSE, but were positively associated with rates of diagnosed neonatal abstinence syndrome.</p></div><div><h3>Conclusion</h3><p>State-level inconsistencies in identification, reporting, and CPS responses prevent a clear understanding of the scope of the affected population and service needs.</p></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"130 ","pages":"Article 104527"},"PeriodicalIF":4.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395924002123","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In the U.S., the opioid epidemic has revitalized national attention to newborns with prenatal substance exposure (PSE). These newborns and their caregivers have specific health and treatment needs and frequently interact with multiple systems, including child protection systems (CPS).
Methods
This study calculated rates of newborns (less than 15 days old) reported to CPS per 1,000 births due to PSE by state and year using data from the National Child Abuse and Neglect Data System (NCANDS). Given the lack of a clear definition of PSE reports in the data, we calculated rates using three different definitions. To examine the relationship between different state laws regarding the mandated reporting of PSE and PSE reports rates, we used panel data analysis.
Results
Rates of newborn reports more than doubled between 2011 and 2019. There was extensive state variability of rates including some states that were consistently more than 100 % greater than and others consistently more than 150 % less than the annual national mean. Reporting rates were not associated with state requirements to report PSE, but were positively associated with rates of diagnosed neonatal abstinence syndrome.
Conclusion
State-level inconsistencies in identification, reporting, and CPS responses prevent a clear understanding of the scope of the affected population and service needs.
背景:在美国,阿片类药物的流行重新引起了全国对产前药物接触(PSE)新生儿的关注。这些新生儿及其照顾者有特殊的健康和治疗需求,并经常与包括儿童保护系统(CPS)在内的多个系统发生互动:本研究利用全国虐待和忽视儿童数据系统(NCANDS)的数据,按州和年份计算了每 1000 名新生儿(出生不足 15 天)中因 PSE 而向 CPS 报告的比率。由于数据中缺乏对 PSE 报告的明确定义,我们使用了三种不同的定义来计算比率。为了研究各州关于强制报告 PSE 的法律与 PSE 报告率之间的关系,我们使用了面板数据分析:2011 年至 2019 年间,新生儿报告率增加了一倍多。各州的报告率存在很大差异,其中一些州的报告率始终高于全国年均值的 100%,而另一些州则始终低于全国年均值的 150%。报告率与各州报告 PSE 的要求无关,但与诊断出的新生儿禁欲综合征的比率呈正相关:各州在识别、报告和 CPS 应对措施方面的不一致阻碍了对受影响人群范围和服务需求的清晰了解。
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.